Search | OpenScholar

Search results

196 results found

Red blood cell transfusions increase fecal calprotectin levels in premature infants.

Publication: Journal Article

Ho, T T B, M W Groer, A A Luciano, A Schwartz, M Ji, B S Miladinovic, A Maheshwari, and T L Ashmeade. 2015. “Red Blood Cell Transfusions Increase Fecal Calprotectin Levels in Premature Infants.”. Journal of Perinatology : Official Journal of the California Perinatal Association 35 (10): 837-41.

Leigh-Anne Worthington

Person:

Halade Lab

USF Tina Ho Lab

The Ho lab is a laboratory in USF Health that focuses on understanding gut health in preterm infants with an emphasis on anemia and oral iron supplementation.

Medical Management and Prevention of Motor Complications in Parkinson's Disease. Neurotherapeutics 2020;17:1339-1365.

Publication: Journal Article

Aradi, SD, and RA Hauser. 2020. “Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020;17:1339-1365.”. Neurotherapeutics.

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism Relat Disord 2020;80:127-132.

Publication: Journal Article

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.

Publication: Journal Article

Hauser, RA, and . 2020. “Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.”. Front Neurol.

On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgrad Med. 2021 Sep;133(7):721-727. doi: 10.1080/00325481.2021.1936087.

Publication: Journal Article

Hauser, RA, PA LeWitt, and CL Comella. 2021. “On Demand Therapy for Parkinson’s Disease Patients: Opportunities and Choices. Postgrad Med. 2021 Sep;133(7):721-727. Doi: 10.1080/00325481.2021.1936087.”. Postgrad Med.

A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. doi: 10.3390/s21165437. PMID: 34450879.

Publication: Journal Article

Rupprechter, S, G Morinan, Y Peng, T Foltynie, K Sibley, RS Weil, LA Leyland, et al. 2021. “A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. Doi: 10.3390/S21165437. PMID: 34450879.”. Sensors (Basel).

Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. doi: 10.3233/JPD-212672. PMID: 34486986

Publication: Journal Article

Hauser, RA, N Hattori, H Fernandez, SH Isaacson, H Mochizuki, O Rascol, F Stocchi, et al. 2021. “Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, As Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. Doi: 10.3233/JPD-212672. PMID: 34486986”. J Parkinsons Dis.